FAK

FAK(局部粘附激酶或 PTK2)是一种非受体和非膜相关蛋白酪氨酸激酶,在细胞基质粘附和整合素聚集位点通过自磷酸化(在 Tyr397)、Src 和其他酪氨酸激酶被激活。FAK 通过将调节细胞迁移、粘附和存活的信号从细胞外基质转移到细胞质来介导基于整合素的细胞信号传导。

FAK 在许多肿瘤中过表达,包括来自头颈部、结肠、乳腺、前列腺、肝脏和甲状腺的肿瘤。此外,FAK 过表达与这些肿瘤中的侵袭性表型高度相关。通过过度表达 FAK 的显性负片段来抑制 FAK 信号传导可降低胶质母细胞瘤和卵巢癌细胞的侵袭性。因此,FAK 是开发抗肿瘤和抗转移药物的重要靶点。

FAK (Focal Adhesion Kinase or PTK2) is a non-receptor and non-membrane associated protein tyrosine kinase that is activated at the sites of cell-matrix adhesions and integrin clustering by auto-phosphorylation (at Tyr397), Src, and other tyrosine kinases. FAK mediates integrin-based cell signaling by transferring signals regulating cell migration, adhesion, and survival from the extracellular matrix to the cytoplasm.

FAK is overexpressed in many tumors, including those derived from the head and neck, colon, breast, prostate, liver, and thyroid. Furthermore, FAK overexpression is highly correlated with an invasive phenotype in these tumors. Inhibition of FAK signaling by overexpression of dominant-negative fragments of FAK reduces invasion of glioblastomas and ovarian cancer cells. FAK therefore represents an important target for the development of anti-neoplastic and anti-metastatic drugs.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
PROTAC TG2 Degrader-3

PROTAC TG2 Degrader-3 是一种 TG2 (TGM2) PROTAC 降解剂,可抑制卵巢癌细胞的黏附和迁移,并可用于卵巢癌的研究(粉色:TGM2 配体 (MS-P02154);蓝色:VHL 配体 (MS-F94920);黑色:连接子 (MS-S10954))。

3054388-18-7
Modulator
PROTAC TG2 Degrader-3

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础